Jotec GmbH
Clinical trials sponsored by Jotec GmbH, explained in plain language.
A medical device company specializing in vascular implants, acquired by CryoLife.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Researchers check safety of stent grafts used in aortic aneurysm surgery Results expected Sep 2026 (estimated)
-
New stent graft aims to fix dangerous aortic aneurysms without open surgery
Disease control OngoingThis study is testing a device called the E-nside stent graft system in 30 people with thoracoabdominal aortic aneurysms (a bulge in the main artery that runs through the chest and belly). The goal is to see if the device is safe and works well when placed inside the artery to re…
Sponsor: JOTEC GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New stent graft aims to prevent deadly aneurysm rupture
Disease control OngoingThis study is testing a special stent graft system designed to treat thoracoabdominal aortic aneurysms, a life-threatening condition where the main artery bulges. The device is placed inside the artery to support the weakened wall and prevent rupture. Researchers are following 15…
Sponsor: JOTEC GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New stent registry aims to improve aortic dissection outcomes
Disease control OngoingThis study is a registry that collects information on the AMDS stent, a device used to treat a life-threatening tear in the aorta (the main artery). The registry includes 301 adults aged 18-80 with acute DeBakey type I aortic dissection or intramural hematoma. The goal is to see …
Sponsor: JOTEC GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC